Showing results (491-500 of 539) with videos related to

Sort By:
Pageof 54
Rheumatology (Oxford, England)|April 6, 2022
Characterization and outcomes of 414 patients with primary SS who developed haematological malignanciesGabriela Hernández-Molina, Belchin Kostov, Pilar Brito-Zerón, et al.
RMD Open|November 1, 2022
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, et al.
Annals of the Rheumatic Diseases|December 13, 2012
Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritisMaša Umiċeviċ Mirkov, Jing Cui, Sita H Vermeulen, et al.
JAMA|September 23, 2016
Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical TrialJacques-Eric Gottenberg, Olivier Brocq, Aleth Perdriger, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
The Lancet. Rheumatology|January 22, 2024
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 studyGrégoire Martin de Frémont, Nathalie Costedoat-Chalumeau, Estibaliz Lazaro, et al.
Annals of the Rheumatic Diseases|December 1, 2016
Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project ConsortiumPilar Brito-Zerón, Nihan Acar-Denizli, Margit Zeher, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
The Lancet. Rheumatology|January 17, 2024
Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trialsJessica R Tarn, Nadia Howard-Tripp, Dennis W Lendrem, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Pageof 54